All In Biotech

Drug Trial Radar · NCT06133972

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

A Randomized, Double-blind, Placebo-controlled Extension Study, Followed by a Study Treatment Withdrawal or Open-label Period, to Assess the Long-term Safety and Tolerability of Ianalumab in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE Extension)

Last checked: Nov 20, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 550 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

550

Planned (sponsor's estimate)

Start

May 21, 2024

Primary completion

Apr 3, 2034

Study completion Oct 2, 2034

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
First posted
Nov 18, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate long-term safety and tolerability of ianalumab in participants with systemic lupus erythematosus who have previously completed the treatment period in one of the two SIRIUS-SLE core studies (CVAY736F12301 or CVAY736F12302).

Conditions

  • Systemic Lupus Erythematosus

Interventions

  • PlaceboDrug

    Placebo s.c. monthly

  • IanalumabDrug

    Ianalumab s.c. monthly Ianalumab s.c. quarterly

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of treatment-emergent Adverse events/Serious Adverse eventsTime frame: through study completion, up to approximately 324 weeks

Locations

167 sites in 29 countries. Site status is shown where the registry gives one.

  • Pinnacle Research Group Llc

    Anniston, Alabama · Recruiting

  • Providence Medical Center

    Burbank, California · Recruiting

  • Advanced Medical Research

    La Palma, California · Recruiting

  • Millennium Clinical Trials

    Westlake Village, California · Active not recruiting

  • University of Colorado Denver

    Aurora, Colorado · Recruiting

  • Clinical Res Of W Florida

    Clearwater, Florida · Recruiting

  • GNP Research

    Cooper City, Florida · Recruiting

  • Homestead Assoc In Research Inc

    Homestead, Florida · Recruiting

  • IRIS Research and Development

    Plantation, Florida · Recruiting

  • Clinical Research of West Florida Inc

    Tampa, Florida · Recruiting

  • Parris and Associates Rheumatology

    Lawrenceville, Georgia · Recruiting

  • Robert A Hozman MD SC

    Skokie, Illinois · Completed

  • Willow Rheumatology Wellness

    Willowbrook, Illinois · Recruiting

  • Accurate Clinical Research

    Lake Charles, Louisiana · Recruiting

  • UMC New Orleans

    New Orleans, Louisiana · Active not recruiting

  • University Of Maryland

    Baltimore, Maryland · Active not recruiting

  • Henry Ford Health

    Detroit, Michigan · Recruiting

  • Ahmed Arif Medical Research Center

    Grand Blanc, Michigan · Recruiting

  • Paramount Med Rsrch and Consult LLC

    Middleburg Heights, Ohio · Recruiting

  • University Of Pittsburgh

    Pittsburgh, Pennsylvania · Recruiting

  • West Tennessee Research Institute

    Jackson, Tennessee · Recruiting

  • Shelby Research LLC

    Memphis, Tennessee · Recruiting

  • Novel Research LLC

    Bellaire, Texas · Recruiting

  • Accurate Clinical Research

    League City, Texas · Recruiting

  • Epic Medical Research

    Red Oak, Texas · Recruiting

  • Novartis Investigative Site

    Caba, Argentina · Active not recruiting

  • Novartis Investigative Site

    Caba, Argentina · Recruiting

  • Novartis Investigative Site

    San Miguel de Tucumán, Argentina · Active not recruiting

  • Novartis Investigative Site

    La Plata, Buenos Aires, Argentina · Recruiting

  • Novartis Investigative Site

    Quilmes, Buenos Aires, Argentina · Recruiting

  • Novartis Investigative Site

    San Miguel, Buenos Aires, Argentina · Active not recruiting

  • Novartis Investigative Site

    San Miguel, Tucumán Province, Argentina · Active not recruiting

  • Novartis Investigative Site

    Maroochydore, Queensland, Australia · Recruiting

  • Novartis Investigative Site

    Salvador, Brazil · Recruiting

  • Novartis Investigative Site

    Vitória, Espírito Santo, Brazil · Recruiting

  • Novartis Investigative Site

    Salvador, Estado de Bahia, Brazil · Recruiting

  • Novartis Investigative Site

    Belo Horizonte, Minas Gerais, Brazil · Active not recruiting

  • Novartis Investigative Site

    Curitiba, Paraná, Brazil · Recruiting

  • Novartis Investigative Site

    Niterói, Rio de Janeiro, Brazil · Active not recruiting

  • Novartis Investigative Site

    Rio de Janeiro, Rio de Janeiro, Brazil · Recruiting

Showing 40 of 167 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.